Restriction Spectrum Imaging Differentiates True Tumor Progression From Immune-Mediated Pseudoprogression: Case Report of a Patient With Glioblastoma

Immunotherapy is increasingly used in the treatment of glioblastoma (GBM), with immune checkpoint therapy gaining in popularity given favorable outcomes achieved for other tumors. However, immune-mediated (IM)-pseudoprogression is common, remains poorly characterized, and renders conventional imagin...

Descripción completa

Detalles Bibliográficos
Autores principales: Daghighi, Shadi, Bahrami, Naeim, Tom, William J., Coley, Nicholas, Seibert, Tyler M., Hattangadi-Gluth, Jona A., Piccioni, David E., Dale, Anders M., Farid, Nikdokht, McDonald, Carrie R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997150/
https://www.ncbi.nlm.nih.gov/pubmed/32047723
http://dx.doi.org/10.3389/fonc.2020.00024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997150/
https://www.ncbi.nlm.nih.gov/pubmed/32047723
http://dx.doi.org/10.3389/fonc.2020.00024

Ejemplares similares